We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells.
- Authors
Larsson, Pia; Bergh, Niklas; Lu, Emma; Ulfhammer, Erik; Magnusson, Mia; Wåhlander, Karin; Karlsson, Lena; Jern, Sverker
- Abstract
A reduced capacity for acute tissue-type plasminogen activator (t-PA) release is likely to be associated with an impaired endogenous defense against intravascular thrombosis. Efficient approaches to pharmacologically restore a defective t-PA release have been lacking, but recent observations suggest that histone deacetylase inhibitors (HDACis) enhance t-PA production in vitro. HDACis have diverse chemical structures and different HDAC-enzyme sub-class targeting. We here compared the effects of several clinically used HDACis on t-PA production in endothelial cells. Human umbilical vein endothelial cells were exposed to a panel of 11 different HDACis and t-PA mRNA and protein levels were quantified. All HDACis dose-dependently stimulated t-PA mRNA and protein expression with similar maximal efficacy but with different potencies. Already at low concentrations, the majority of inhibitors caused significant and sustained effects on t-PA production. In addition, selected HDACis were capable of normalizing t-PA production when suppressed by the inflammatory cytokine TNF-α. We conclude that HDACis targeting classical HDAC enzymes are powerful inducers of t-PA expression in cultured endothelial cells and could be promising candidates for pharmacological modulation of endogenous fibrinolysis in man.
- Publication
Journal of thrombosis and thrombolysis, 2013, Vol 35, Issue 2, p185
- ISSN
1573-742X
- Publication type
Journal Article
- DOI
10.1007/s11239-012-0831-6